Oral contraceptive use and hyperhomocysteinemia are considered to be relati
vely weak risk factors for venous thromboembolism, We report a case of acut
e renal vein thrombosis, a rare and aggressive form of thromboembolism, tha
t occurred in a 21-year-old woman taking oral contraceptives, who was subse
quently found to have marked hyperhomocysteinemia. This case suggests that
the oral contraceptive and hyperhomocysteinemia may interact in a synergist
ic manner in the pathogenesis of thrombosis. In oral contraceptive users wh
o develop venous thrombosis in the absence of other risk factors, clinician
s should consider investigations for an underlying prothrombotic biochemica
l disorder.